#1CHANG IZ EH | Nasdaq Listed EHang Holdings Limited Q4 and FY 2021 Earnings Highlights March 29, 2022 CHANGIZAR **** 1#2Disclaimer These materials have been prepared by EHang Holdings Limited (the "Company") solely for informational purposes and have not been independently verified. No representations or warranties, express or implied, are made as to, and no reliance should be placed on, the accuracy, fairness, completeness or correctness of the information or opinions presented or contained in these materials. None of the Company, its subsidiaries, affiliates, controlling persons, directors, supervisors, officers, partners, employees, advisors, and representatives of any of the foregoing shall have any responsibility or liability whatsoever, as a result of negligence or otherwise, for any loss howsoever arising from any information or opinions presented or contained in or derived from these materials. The information and opinions presented or contained in these materials is subject to change without notice and shall only be considered current as of the date of the presentation. This presentation includes forward-looking statements, which are based on current expectations and forecast about future events. These statements can be recognized by the use of words such as "expect," "plan,” “will,” “estimate," "project," "intend," or words of similar meaning. These forward-looking statements are made only and are based on estimates and information available to the Company, as of the date of this presentation, and are not guarantees of future performance. These statements are based on a number of assumptions which are subject to known and unknown risks, uncertainties and other factors that are beyond the Company's control, which could cause actual results to differ materially from historical results or those anticipated. These factors include, but are not limited to, the political, social, legal and economic environment in which the Company will operate in the future. The Company and its affiliates and representatives undertake no obligation to update or revise these forward-looking statements for events or circumstances that occur subsequent to the date of this presentation. Actual results could differ materially from those anticipated in forward-looking statements and future results could materially differ from our historical performance. This presentation is not and does not constitute or form part of, and is not made in connection with, any offer, invitation or recommendation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities of any entity, and neither this presentation nor anything contained in it shall form the basis of, or be relied upon in connection with, any contract or investment decision. Certain data in this presentation was obtained from various external data sources, and the Company has not verified such data with independent sources. Accordingly, the Company makes no representations as to the accuracy or completeness of that data, and such data involves risks and uncertainties and is subject to change based on various factors. The figures in this document may have been subject to rounding. This presentation speaks as of March 29, 2022. The information presented or contained in this presentation is subject to change without notice. Neither the delivery of this presentation nor any further discussions of the Company, any of its affiliates, shareholders, directors, employees, agents or advisors with any of the recipients shall, under any circumstances, create any implication that there has been no change in the affairs of the Company since that date. By attending this presentation and viewing and accessing these materials, you agree to keep these materials strictly confidential and be bound by the limitations set forth herein. These materials are being given solely for your use and may not be retained, copied, reproduced, redistributed or otherwise disclosed, directly or indirectly to any other person in any manner, or published, in whole or in part, for any purpose. Any failure to comply with these restrictions may constitute a violation of applicable securities laws. CHANGIZAR 2#3CHANG OPERATIONAL HIGHLIGHTS FOR Q4 AND FY 2021 AND RECENT DEVELOPMENTS DIE CHANGIZAR 3#4Progress of the CAAC* Type Certification ("TC") for EH216-S AAV 2021.01 TC application accepted by the CAAC 2021.04 Expert team established by the CAAC 2021.12 Draft Special Conditions for EH216-S TC published by the CAAC for public opinions *Note: CAAC represents the Civil Aviation Administration of China CHANGIZAR 2022.02 Special Conditions for EH216-S TC formally adopted by the CAAC In Progress PSCP CP Compliance Review 2022 Type Certificate Expected to Be Issued#54,000+ Operational Trial Flights Conducted under 100 Air Mobility Routes Initiative * 4,000+ operational trial flights were conducted in various practical scenarios * Objective: ✓ To develop 100 air mobility routes with an initial focus on the Guangdong-Hong Kong-Macao Greater Bay Area of China. Use Cases: ✓ Aerial Tourism Sightseeing ✓ Suburban Transportation ✓✔ Cross-Island Transportation ✓ Aerial Logistics * Note: as of March 29, 2022 CHANG IZAR mi 9 operation spots such as Guangzhou, Hezhou, Shenzhen, Zhaoqing and Sanya LE www www 5#6Partnerships on UAM and Smart City Projects in Major Chinese Cities 56 Or * w e Shenzhen Expressway Guangzhou Development District Communications Investment Group Qintang District Urban Construction Investment Group ✓ Cooperation in smart city transportation network ✓ Shenzhen's first AAV command-and-control platform for expressway network management, emergency rescue and safety operations ✓ Established a JV company for AAV operations ✓ Launched the 5G Intelligent Air Mobility Experience Center as an AAV operation spot in the urban area of Guangzhou ✓ Planned operational flight routes ✓ Procurement plan for estimated 60 units of the EH216-S AAVS with RMB138 million budget * ✓ For Intelligent Air Mobility and Urban Management Infrastructure Project in Qintang District, Guigang city, Guangxi Province, China Source: http://ggzy.jgswj.gxzf.gov.cn/gxggzy/projectDetails.html?infoid=4e4f14cc-fa3b-4955-b9d1-ed3a4e539956&categorynum=001002005001 CHANGIZAR#7Sizable AAV Pre-Orders and Growing UAM Market Demand from Asian Countries INDONESIA prestige corp ✓ Debut demo flight in Bali ✓ Cooperation with Prestige Aviation, a local partner that aspires to be the pioneer in providing smart city innovations with digital-based transport implementation in Indonesia CHANG IZAR MASC OKAYAMA KURASHIKI MIZUSHIMA AERO & SPACE INDUSTRY CLUSTER STUDY GROUP ✓ The first order for VT-30 ✓ EH216 demo flights in Fukushima and Okayama ✓ Cooperation with the MASC to explore use cases with the EH216 and VT-30 and develop the UAM network in Japan CHANG ZAK pre-sale signing ceremony CHANG 2an Air 6 pre-sale signing ceremo JAPAN CHANGUZM AirX EH216 pre-sale signing cerem AirX ✓ Pre-order for 50 units of the EH216 series from AirX Inc., a leading Japanese air mobility digital platform company ✓ Plan to facilitate UAM projects in Japan and has a prospect of providing "air taxi" services for the 2025 World Expo in Osaka, Kansai, Japan CHANG IZAR × AEROTREE CHANE MA Strategic Partnership & Pre-order Contract Signing Ceremony NG Op 201 NG MALAYSIA ZETTE CHANGA Strategic Partnerio & Pro-ord Contract blaning Cony LANG ANG FROTR AEROTREE ✓ Pre-order for 50 units of EH216 series and 10 units of VT-30 from AEROTREE, a leading Malaysian aviation company ✓ Strategic partnership for developing UAM businesses, including MRO and training in Malaysia AERO ANG 201 7#8Unfulfilled Pre-Orders" for EHang Passenger-Grade AAVS ✓ As of March 29, 2022, we have unfulfilled pre- orders for over 1,000 units of our passenger- grade AAV products, including the EH216 series and the VT-30, on a cumulative basis. ✓ The growing market demand has formed a solid foundation that strengthens our confidence for future revenue growth. 164 Unfulfilled pre-orders from customers including but not limited to: AEROTREE Air MASC OKAYAMA KURASHIKI MIZUSHIMA AERO & SPACE INDUSTRY CLUSTER STUDY GROUP United Therapeutics с ORPORATION 1000+ VT-30 EH216 Series 2) Fulfilled Orders Unfulfilled Pre-Orders 1) Pre-orders do not obligate the customers to purchase EHang's AAVS unless certain conditions are satisfied. Fulfilment is expected to take several years and is conditional upon, among other things, achievement of performance milestones and receipt of regulatory approvals. 2) The EH216 series include EH216-S, EH216-L and EH216-F. CHANG IZAR 8#9CHANG FINANCIAL HIGHLIGHTS FOR Q4 AND FY 2021 CHANGIZAR 9#10Q4 2021 and FY 2021 Financial Summary ● Annual Gross Margin Reached 63.4% (RMB ¹000, except for percentages) Total revenues Gross profit Gross margin Adjusted gross profit ¹) Adjusted gross margin Adjusted operating expenses Adjusted operating loss ¹) Adjusted net loss ¹) (RMB '000) 1) 1) Cash, cash equivalents, restricted cash and short-term investments CHANGIZAR Q4 2021 (Unaudited) 8,701 5,227 60.1% 5,227 60.1% (90,422) (83,771) (82,207) Q3 2021 (Unaudited) 12,965 8,010 61.8% 8,010 61.8% (61,833) (48,878) (47,800) As of December 31, 2021 (Unaudited) 312,131 FY2021 (Unaudited) 56,807 36,030 63.4% 36,030 63.4% (246,634) (199,405) (192,765) Notes: 1) The Company uses Non-GAAP Financial Measures in evaluating its operating results and for financial and operational decision-making purposes. Please refer to the press release for more details. FY2020 (Audited) 180,093 106,179 59.0% 108,622 60.3% (151,637) (36,439) (37,184) As of December 31, 2020 (Audited) 189,444 10#11Condensed Consolidated Balance Sheets (RMB '000) Current assets: Cash and cash equivalents Restricted cash Short-term investments Accounts receivable Cost and estimated earnings in excess of billings Inventories, net Prepayments and other current assets Others, net Total current assets Non-current assets: Property and equipment, net Long term loans receivable Long-term investments Others, net Total non-current assets Total assets Current liabilities: Short-term bank loans Accounts payable Contract liabilities Current portion of long-term bank loans Accrued expenses and other liabilities Others, net Total current liabilities Non-current liabilities: Long-term bank loans Mandatorily redeemable non-controlling interests Others, net Total non-current liabilities Total liabilities Total shareholders' equity Total liabilities and shareholders' equity CHANG IZAR As of December 31, 2020 (Audited) 137,840 2,333 49,271 163,146 717 47,094 21,421 2,639 424,461 20,869 14,934 2,919 21,366 60,088 484,549 15,000 53,147 7,492 81,578 830 158,047 40,000 8,802 48,802 206,849 277,700 484,549 As of December 31, 2021 (Unaudited) 246,863 160 65,108 56,189 78,075 29,395 1,360 477,150 33,821 15,208 6,143 3,112 58,284 535,434 10,000 45,560 14,831 3,000 61,851 1,205 136,447 17,000 40,000 7,941 64,941 201,388 334,046 535,434 11#12Condensed Consolidated Statements of Comprehensive Loss 2021 Q3 (Unaudited) 12,965 (4,955) 8,010 (RMB '000) Total revenues Costs of revenues Gross profit Operating expenses: Sales and marketing expenses General and administrative expenses Research and development expenses Total operating expenses Other operating income Operating loss Other income (expense): Interest and investment income Interest expenses Foreign exchange loss Other (expense) income Total other (expense) income Loss before income tax and (loss) income from equity method investment Income tax expenses Loss before (loss) income from equity method investment (Loss) income from equity method investment Net loss Net loss (income) attributable to non-controlling interests Net loss attributable to ordinary shareholders CHANG IZAR (10,740) (36,845) (38,699) (86,284) 4,945 (73,329) 1,427 (474) (162) 299 1,090 (72,239) (12) (72,251) (72,251) 276 (71,975) 2021 Q4 (Unaudited) 8,701 (3,474) 5,227 (12,241) (61,675) (38,826) (112,742) 1,424 (106,091) 1,198 (461) (397) 1,505 1,845 (104,246) (5) (104,251) (276) (104,527) (897) (105,424) FY 2020 (Audited) 180,093 (73,914) 106,179 (37,186) (61,613) (105,252) (204,051) 6,576 (91,296) 3,795 (2,337) (333) (1,900) (775) (92,071) (206) (92,277) 236 (92,041) 4,422 (87,619) FY 2021 (Unaudited) 56,807 (20,777) 36,030 (43,229) (187,388) (137,148) (367,765) 11,199 (320,536) 5,143 (1,803) (827) 4,537 7,050 (313,486) (134) (313,620) (276) (313,896) (63) (313,959) 12#13Investment Highlights CHANG IZAR 1. World's First Publicly Traded Urban Air Mobility Company 2. Massive, Fast-Growing Target Market Ready for True Disruption 3. 4. 5. Global Market Leader and First Mover of Commercialization Ahead of Competition World's Leading Scalable Urban Air Mobility Platform with Integrated Product Suite Continuous, Industry-Disruptive Regulatory Breakthroughs 6. Compelling High Growth and Margin Business Model 7. Ecosystem Enabler with Global Partnership Network 8. Experienced and Entrepreneurial Management Team 13#14THANK YOU www.ehang.com CHANG IZAñ car Investor Contact: [email protected] B62 6 SHING 14